Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
1.300
-0.030 (-2.26%)
At close: Sep 12, 2025, 4:00 PM EDT
1.290
-0.010 (-0.77%)
After-hours: Sep 12, 2025, 4:10 PM EDT

Envoy Medical Statistics

Total Valuation

Envoy Medical has a market cap or net worth of $27.76 million. The enterprise value is $51.31 million.

Market Cap27.76M
Enterprise Value 51.31M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, after market close.

Earnings Date Nov 13, 2025
Ex-Dividend Date n/a

Share Statistics

Envoy Medical has 21.52 million shares outstanding. The number of shares has increased by 21.98% in one year.

Current Share Class 21.52M
Shares Outstanding 21.52M
Shares Change (YoY) +21.98%
Shares Change (QoQ) +0.27%
Owned by Insiders (%) 37.83%
Owned by Institutions (%) 62.92%
Float 10.85M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 117.20
Forward PS 117.07
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 231.12
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.94

Current Ratio 0.94
Quick Ratio 0.67
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11.15

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -148.00%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -1,036.74%
Revenue Per Employee $5,286
Profits Per Employee -$671,524
Employee Count42
Asset Turnover 0.03
Inventory Turnover 0.51

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -59.12% in the last 52 weeks. The beta is 2.18, so Envoy Medical's price volatility has been higher than the market average.

Beta (5Y) 2.18
52-Week Price Change -59.12%
50-Day Moving Average 1.43
200-Day Moving Average 1.52
Relative Strength Index (RSI) 46.37
Average Volume (20 Days) 789,844

Short Selling Information

The latest short interest is 301,387, so 1.40% of the outstanding shares have been sold short.

Short Interest 301,387
Short Previous Month 93,613
Short % of Shares Out 1.40%
Short % of Float 2.78%
Short Ratio (days to cover) 0.48

Income Statement

In the last 12 months, Envoy Medical had revenue of $222,000 and -$28.20 million in losses. Loss per share was -$1.40.

Revenue222,000
Gross Profit -582,000
Operating Income -19.70M
Pretax Income -23.04M
Net Income -28.20M
EBITDA -19.46M
EBIT -19.70M
Loss Per Share -$1.40
Full Income Statement

Balance Sheet

The company has $5.29 million in cash and $28.83 million in debt, giving a net cash position of -$23.55 million or -$1.09 per share.

Cash & Cash Equivalents 5.29M
Total Debt 28.83M
Net Cash -23.55M
Net Cash Per Share -$1.09
Equity (Book Value) -29.86M
Book Value Per Share -1.39
Working Capital -487,000
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$15.90 million and capital expenditures -$88,000, giving a free cash flow of -$15.99 million.

Operating Cash Flow -15.90M
Capital Expenditures -88,000
Free Cash Flow -15.99M
FCF Per Share -$0.74
Full Cash Flow Statement

Margins

Gross Margin -262.16%
Operating Margin -8,872.97%
Pretax Margin -9,579.28%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Envoy Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.98%
Shareholder Yield n/a
Earnings Yield -101.59%
FCF Yield -57.59%

Analyst Forecast

The average price target for Envoy Medical is $9.25, which is 611.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.25
Price Target Difference 611.54%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Envoy Medical has an Altman Z-Score of -48.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -48.13
Piotroski F-Score 2